X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4242) 4242
Book Chapter (43) 43
Book / eBook (27) 27
Magazine Article (16) 16
Web Resource (5) 5
Conference Proceeding (4) 4
Government Document (3) 3
Newspaper Article (3) 3
Reference (2) 2
Book Review (1) 1
Newsletter (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (2569) 2569
humans (2555) 2555
animals (2151) 2151
female (1844) 1844
male (1726) 1726
endocrine system (1371) 1371
endocrine system diseases (947) 947
mice (801) 801
rats (716) 716
research article (663) 663
endocrinology & metabolism (591) 591
medicine (584) 584
adult (575) 575
research (574) 574
diabetes (557) 557
toxicology (534) 534
rodents (509) 509
pregnancy (500) 500
middle aged (495) 495
multidisciplinary sciences (465) 465
risk factors (460) 460
health aspects (456) 456
endocrine disruptors (434) 434
hormones, hormone substitutes, and hormone antagonists (427) 427
endocrine system diseases - chemically induced (408) 408
science (398) 398
cancer (396) 396
insulin (395) 395
analysis (381) 381
environmental sciences (373) 373
gene expression (371) 371
disease models, animal (359) 359
oncology (357) 357
studies (344) 344
aged (343) 343
endocrinology (341) 341
proteins (332) 332
nutritional and metabolic diseases (331) 331
expression (327) 327
exposure (304) 304
endocrine disruptors - toxicity (301) 301
public, environmental & occupational health (301) 301
cell biology (295) 295
physiological aspects (295) 295
hormones (292) 292
care and treatment (286) 286
diabetes mellitus (285) 285
bisphenol-a (284) 284
metabolism (282) 282
glucose (276) 276
review (255) 255
obesity (254) 254
physiology (254) 254
apoptosis (249) 249
mice, inbred c57bl (240) 240
biology (239) 239
medicine, research & experimental (236) 236
inflammation (235) 235
breast cancer (233) 233
oxidative stress (233) 233
pharmacology & pharmacy (230) 230
time factors (224) 224
neurosciences (222) 222
bisphenol a (220) 220
in-vitro (220) 220
signal transduction (219) 219
child (215) 215
risk (215) 215
biochemistry (213) 213
type 2 diabetes (212) 212
rats, sprague-dawley (211) 211
estrogen (205) 205
endocrine-disrupting chemicals (201) 201
adolescent (200) 200
dose-response relationship, drug (199) 199
gene-expression (196) 196
insulin resistance (194) 194
environmental pollutants - toxicity (192) 192
kinases (190) 190
risk assessment (189) 189
biochemistry & molecular biology (185) 185
rats, wistar (184) 184
toxicity (182) 182
medicine & public health (178) 178
immunology (176) 176
abridged index medicus (173) 173
internal medicine (173) 173
complications and side effects (172) 172
tumors (172) 172
article subject (171) 171
biology and life sciences (171) 171
hypoglycemia - chemically induced (171) 171
medicine and health sciences (171) 171
original (171) 171
environmental exposure - adverse effects (170) 170
medical research (167) 167
phenols - toxicity (167) 167
genetic aspects (166) 166
hyperglycemia (164) 164
development and progression (161) 161
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4195) 4195
French (40) 40
German (29) 29
Japanese (23) 23
Italian (19) 19
Russian (19) 19
Spanish (13) 13
Portuguese (5) 5
Polish (4) 4
Czech (3) 3
Danish (3) 3
Dutch (2) 2
Swedish (2) 2
Chinese (1) 1
Finnish (1) 1
Hungarian (1) 1
Romanian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


CA: a cancer journal for clinicians, ISSN 0007-9235, 2013, Volume 63, Issue 4, pp. 249 - 279
... classes that affect virtually every organ system in the body. Early termination of the clinical development of some of these drugs was prompted by unanticipated... 
toxicity | kinase inhibitors | therapeutic index | targeted agents | mechanism‐based toxicity | immunotherapeutic agents | off‐target toxicity | mechanism-based toxicity | off-target toxicity | MEK INHIBITOR TRAMETINIB | PULMONARY ARTERIAL-HYPERTENSION | I DOSE-ESCALATION | CHRONIC MYELOID-LEUKEMIA | GROWTH-FACTOR RECEPTOR | ONCOLOGY | PLACEBO-CONTROLLED TRIAL | III CLINICAL-TRIAL | SQUAMOUS-CELL CARCINOMAS | TIVANTINIB ARQ 197 | SIGNAL-REGULATED KINASE | Mood Disorders - chemically induced | Drug Eruptions - etiology | Peripheral Nervous System Diseases - chemically induced | Bone Marrow Diseases - chemically induced | Cachexia - chemically induced | Endocrine System Diseases - chemically induced | Pleural Effusion - chemically induced | Humans | Drug Eruptions - therapy | Immune System Diseases - chemically induced | Lung Diseases, Interstitial - chemically induced | Thrombocytopenia - chemically induced | Diarrhea - chemically induced | Neoplasms - drug therapy | Antineoplastic Agents - adverse effects | Exanthema - chemically induced | Hyperbilirubinemia - chemically induced | Venous Thromboembolism - chemically induced | Vision Disorders - chemically induced | Hemorrhage - chemically induced | Heart Diseases - chemically induced | Hyperlipidemias - chemically induced | Magnesium - blood | Antimitotic agents | Drugs | Prevention | Complications and side effects | Drug targeting | Antineoplastic agents | Health aspects | Risk factors | Proteins | Side effects | Genomics | Cytotoxicity | Molecular biology | Cancer therapies | Cells | Index Medicus | Abridged Index Medicus
Journal Article
International journal of dermatology, ISSN 1365-4632, 2010, Volume 49, Issue 3, pp. 239 - 248
Background  Systemic glucocorticoids are used in dermatologic practice for various diseases including connective tissue disorders, bullous diseases, and many other dermatologic conditions... 
MINERAL DENSITY | PREDNISONE TREATMENT | STEROID-INDUCED OSTEOPOROSIS | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | ACTIVE RHEUMATOID-ARTHRITIS | REPLACEMENT THERAPY | LUPUS-ERYTHEMATOSUS | CORTICOSTEROID-INDUCED OSTEOPOROSIS | PEPTIC-ULCER DISEASE | INDUCED BONE LOSS | DERMATOLOGY | Glucocorticoids - therapeutic use | Endocrine System Diseases - chemically induced | Cardiovascular Diseases - drug therapy | Cardiovascular Diseases - prevention & control | Humans | Male | Metabolic Diseases - drug therapy | Osteoporosis - drug therapy | Femur Head Necrosis - drug therapy | Central Nervous System Diseases - prevention & control | Femur Head Necrosis - prevention & control | Gastrointestinal Diseases - drug therapy | Musculoskeletal Diseases - chemically induced | Aged, 80 and over | Female | Endocrine System Diseases - drug therapy | Glucocorticoids - adverse effects | Musculoskeletal Diseases - prevention & control | Musculoskeletal Diseases - drug therapy | Endocrine System Diseases - prevention & control | Osteoporosis - chemically induced | Osteoporosis - prevention & control | Gastrointestinal Diseases - prevention & control | Metabolic Diseases - chemically induced | Skin Diseases - drug therapy | Femur Head Necrosis - chemically induced | Central Nervous System Diseases - chemically induced | Central Nervous System Diseases - drug therapy | Aged | Cardiovascular Diseases - chemically induced | Metabolic Diseases - prevention & control | Gastrointestinal Diseases - chemically induced | Prevention | Complications and side effects | Usage | Care and treatment | Corticosteroids | Skin diseases | Steroids
Journal Article
Endocrine Reviews, ISSN 1945-7189, 2015, Volume 36, Issue 6, pp. E1 - E150
Journal Article